AI takes on rare brain tumors: a new hope for personalized care

NCT ID NCT06878469

Recruiting now Knowledge-focused Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to standardize care for people with rare brain tumors by using artificial intelligence to analyze patient data and predict recovery after surgery. Researchers will collect information on symptoms, brain scans, and cognitive function from 200 adults undergoing tumor removal. Participants will also do a home-based cognitive rehabilitation program to help improve their quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm meningioma primary brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN TUMORS

Contacts and locations

Locations

ASL 1 Abruzzo Avezzano-Sulmona-L'Aquila
NOT_YET_RECRUITING

L’Aquila, 67100, Italy
Fondazione IRCCS Istituto Neurologico Carlo Besta
RECRUITING

Milan, PA, 20133, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.